Qing Hao Artemisinin.

The peroxide bridge that defines artemisinin is cleaved by ferrous iron and heme to give carbon-centred radicals, which is the chemical basis of what the molecule does. Iron status changes how much radical chemistry a given dose produces.

Alpha-tocopherol is a chain-breaking antioxidant that intercepts the carbon and oxygen radicals artemisinin generates. Large antioxidant doses taken alongside it work against the reaction the molecule depends on.

NAC raises intracellular glutathione, and thiols react directly with the radical species produced when the endoperoxide opens. A high thiol load blunts that oxidative chemistry rather than adding to it.

Hyperforin strongly induces CYP3A4 and CYP2B6, the same enzymes that clear artemisinin and its derivatives. Co-dosing lowers circulating levels of artemisinin from a given dose.

Piperine slows CYP3A4 and intestinal glucuronidation, the routes that remove artemisinin quickly from circulation. That raises exposure from an unchanged dose, which cuts both ways and belongs on the label.

Artemisinin is poorly water soluble, and dissolving it in a medium-chain triglyceride carrier raises how much dissolves in the gut before absorption. Taking it with dietary fat has the same effect.

Ascorbate reduces ferric to ferrous iron, which can increase activation of the endoperoxide, but at high concentration it also quenches the radicals that activation produces. The net direction depends on dose, so the pairing needs care rather than assumption.

Artemisinin and its derivatives are cleared largely by CYP2B6 and CYP3A4, and silymarin constituents modulate CYP3A4 and UGT-mediated glucuronidation in laboratory systems. Combining them can shift how quickly the artemisinin is cleared, in either direction. This is a pharmacokinetic consideration to raise with a clinician, not a benefit to seek.

Curcumin inhibits CYP3A4 and P-glycoprotein in laboratory systems, both of which handle artemisinin-class compounds. Co-administration is therefore likely to change exposure rather than leave it untouched. The direction and size in people have not been established.

Schisandra lignans are among the better-characterised botanical modulators of CYP3A activity and P-glycoprotein, and schisandra is a common companion herb in traditional formulas that also carry qing hao. Combining the two puts a CYP3A modulator alongside a CYP3A substrate. Exposure to the artemisinin may change as a result.

Quercetin inhibits CYP3A4 and several transporters in laboratory work, and it also chelates iron. Both properties intersect with artemisinin handling, since iron and heme are what cleave the endoperoxide bridge. The net direction of the combination has not been measured in people.

Artemisinin's defining chemistry is the iron-dependent cleavage of its endoperoxide bridge into carbon-centred radicals. Thiol antioxidants scavenge radicals and support glutathione S-transferase mediated conjugation, so a high thiol load works against that chemistry rather than with it. This mirrors the anti-synergy already recorded for N-acetylcysteine.

Alpha-lipoic acid is a strong reducing agent in both its oxidised and reduced forms and regenerates other cellular antioxidants. Artemisinin depends on radical generation for its characteristic activity. A reducing environment is the opposite of what that chemistry requires.

Lactoferrin binds ferric iron tightly, and artemisinin's endoperoxide bridge is activated by ferrous iron and heme. Sequestering iron reduces the pool available for that activation step. The reasoning is mechanistic and has not been tested as a combination.

Catechins chelate iron and act as reducing agents, two properties that both work against iron-dependent endoperoxide cleavage. Green tea extract also modulates several CYP enzymes. The combination touches artemisinin handling at two points and neither has been quantified.

Artemisinin dissolves poorly in both water and oil, which is the main limit on how much of an oral dose gets absorbed. Phospholipid dispersion is a standard formulation response to that problem. It is a manufacturing approach rather than a demonstrated pharmacokinetic gain for this compound.

Absorption of lipophilic artemisinin derivatives is greater when taken with a fat-containing meal, a food effect that is well described for this compound class. A fat-based supplement taken alongside provides some of that lipid. The size of the effect depends on the total fat in the meal, not on the supplement alone.

Licorice appears in a large share of traditional Chinese formulas as a harmonising herb, including alongside qing hao. Glycyrrhizin also affects several drug-metabolising enzymes and mineralocorticoid handling. The pairing is traditional; the pharmacology of combining them has not been characterised.